Stay updated on Repotrectinib in Rearranged Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.

Latest updates to the Repotrectinib in Rearranged Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe history shows a new Revision: v3.4.2 added and the prior government funding notice/banner removed. These changes affect only site-wide notices and do not modify the study data, eligibility, or results.SummaryDifference0.3%

- Check22 days agoChange DetectedAdded a government funding lapse notice with status guidance and links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1.SummaryDifference0.3%

- Check29 days agoChange DetectedUI improvements to the record history page include a glossary display option, color-coded change indicators, and an updated revision tag (v3.4.0), with minor capitalization adjustments for FEAR Act text.SummaryDifference0.3%

- Check43 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the history.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the history; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check93 days agoChange DetectedFooter revision metadata updated from v3.2.0 to v3.3.2; no substantive content or functionality changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Repotrectinib in Rearranged Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.